Not medical advice. Talk to your provider before using any peptide.
Full disclaimerPeptide Schedule Research TeamReviewed Apr 20267 Citations
Icatibant (Firazyr) blocks bradykinin B2 receptors during acute hereditary angioedema attacks. FDA-approved since 2011, it delivers symptom relief within 2 hours from a pre-filled syringe. No reconstitution. No IV needed. Retail cost per syringe sits above $11,000 in the US.
30mcg · Single dose
Summary: Add 0mL BAC water to your 30mg vial. Draw to < 0.1 units on a U-100 syringe for a 30mcg dose. This vial will last 0 doses.
View side effects and safety warnings →
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 30mg | Single dose |
| Moderate | 30mg | Single dose |
| Aggressive | 30mg | Single dose |
Icatibant arrives in a pre-filled syringe. No reconstitution math needed here, which is unusual for this platform. The syringe contains 30 mg in 3 mL (10 mg/mL concentration) with a 25-gauge, half-inch needle already attached. You're injecting the full syringe contents every time. Store below 25 degrees Celsius. Don't freeze it. A frozen syringe is a discarded syringe. Keep it in the original packaging away from light. When traveling, bring at least 2 to 3 syringes; one may not be enough for a severe or recurrent attack. The non-obvious thing most beginners miss: speed of injection matters. Thirty seconds minimum for the full 3 mL. Pushing faster makes the site reaction much worse. Some patients use a timer on their phone. For laryngeal attacks, don't wait to see if the drug works before calling emergency services. Inject AND call simultaneously. Airway compromise can progress faster than icatibant's onset of action. One more practical note: keep your attack frequency log current. If you're reaching for icatibant more than once a month, that's a signal to discuss prophylaxis options (lanadelumab, berotralstat, C1-INH replacement) with your HAE specialist.
Dosing based on Firazyr (icatibant) FDA Prescribing Information (2011) — 10 published references.View all sources →
Cross-check your Icatibant (Firazyr) reconstitution math with AI
Pricing updated 2026-04-09
Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →
Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.
Icatibant (Firazyr) blocks bradykinin B2 receptors during acute hereditary angioedema attacks. FDA-approved since 2011, it delivers symptom relief within 2 hours from a pre-filled syringe. No reconstitution. No IV needed. Retail cost per syringe sits above $11,000 in the US.